KR890015732A - 소염성 겔 - Google Patents
소염성 겔 Download PDFInfo
- Publication number
- KR890015732A KR890015732A KR1019890005214A KR890005214A KR890015732A KR 890015732 A KR890015732 A KR 890015732A KR 1019890005214 A KR1019890005214 A KR 1019890005214A KR 890005214 A KR890005214 A KR 890005214A KR 890015732 A KR890015732 A KR 890015732A
- Authority
- KR
- South Korea
- Prior art keywords
- gel
- range
- inflammatory
- ethanolamine
- arginine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (6)
- 겔을 생성하기에 충분한 양의 카르복시비닐 중합체, 용매로서의 물, pH를 pH7.0-9.5의 범위내로 올리기에 충분한 양의 에탄올아민 및/또는 L-아르기닌, 하기 일반식의 구조적 부분을 가지는 비-스테로이달 소염성 약제를 포함하는 소염성 겔 :상기식에서, n은 0또는 1이고 R1및 R2는 각각 수소 또는 알킬이다.
- 제 1 항에 있어서, 소염성 약제가 4-비페닐아세트산인 겔.
- 제 1 항 또는 제 2 항에 있어서, L-아르기닌이 사용된 겔.
- 제 3 항에 있어서, pH가 8.5-9.2의 범위내인 겔.
- 제 1 항 또는 제 2 항에 있어서, 에탄올아민이 사용된 겔.
- 제 5 항에 있어서, pH가 7.1-7.8범위내인 겔.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8809424.8 | 1988-04-21 | ||
GB8809424A GB2217595B (en) | 1988-04-21 | 1988-04-21 | Antiinflammatory gel |
Publications (1)
Publication Number | Publication Date |
---|---|
KR890015732A true KR890015732A (ko) | 1989-11-25 |
Family
ID=10635577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890005214A KR890015732A (ko) | 1988-04-21 | 1989-04-20 | 소염성 겔 |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0338291A1 (ko) |
JP (1) | JPH026407A (ko) |
KR (1) | KR890015732A (ko) |
AU (1) | AU615736B2 (ko) |
DK (1) | DK193089A (ko) |
FI (1) | FI891886A (ko) |
GB (1) | GB2217595B (ko) |
NO (1) | NO891618L (ko) |
NZ (1) | NZ228750A (ko) |
PT (1) | PT90313A (ko) |
ZA (1) | ZA892922B (ko) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2839164B2 (ja) * | 1989-12-25 | 1998-12-16 | 帝國製薬株式会社 | 消炎鎮痛貼付剤 |
US5093133A (en) * | 1990-01-24 | 1992-03-03 | Mcneil-Ppc, Inc. | Method for percutaneous delivery of ibuprofen using hydroalcoholic gel |
GB2260079B (en) * | 1991-10-01 | 1995-08-09 | American Cyanamid Co | Pharmaceutical composition containing felbinac |
US5364884A (en) * | 1993-01-21 | 1994-11-15 | Baylor College Of Medicine | Arginine compounds as ocular hypotensive agents |
GB2305603A (en) * | 1995-09-26 | 1997-04-16 | Allied Medical Group | Topical cooling gels for reducing excess body fat |
US5702720A (en) * | 1995-12-22 | 1997-12-30 | Minnesota Mining And Manufacturing Company | Transdermal device for the delivery of flurbiprofen |
GB9718568D0 (en) | 1997-09-03 | 1997-11-05 | Chauvin Pharmaceuticals Limite | Compositions |
US7914814B2 (en) | 1997-09-17 | 2011-03-29 | Strategic Science & Technologies, Llc | Topical delivery of arginine of cause beneficial effects |
US7629384B2 (en) | 1997-09-17 | 2009-12-08 | Strategic Science & Technologies, Llc | Topical delivery of L-arginine to cause beneficial effects |
FR2797766B1 (fr) * | 1999-08-27 | 2003-04-04 | Menarini France | Nouvelles formes topiques a consistance pateuse sous forme d'un gel distribue en doses |
JP2004123575A (ja) * | 2002-09-30 | 2004-04-22 | Rohto Pharmaceut Co Ltd | 外用ゲル状組成物 |
EP1587798A4 (en) | 2003-01-14 | 2007-06-27 | Merck & Co Inc | NSAID DERIVATIVES WITH GEMINAL DISUBSTITUTION AS ABETA REDUCING AGENTS 42 |
US9226909B2 (en) | 2004-04-19 | 2016-01-05 | Strategic Science & Technologies, Llc | Beneficial effects of increasing local blood flow |
JP2007532697A (ja) * | 2004-04-19 | 2007-11-15 | ストラテジック サイエンス アンド テクノロジーズ, エルエルシー | 局所的血流増大の有益な効果 |
EP2420241A1 (en) * | 2004-04-19 | 2012-02-22 | Strategic Science & Technologies, LLC | Transdermal delivery of beneficial substances effected by a hostile biophysical environment |
US11684624B2 (en) | 2009-06-24 | 2023-06-27 | Strategic Science & Technologies, Llc | Treatment of erectile dysfunction and other indications |
CA2766354C (en) | 2009-06-24 | 2019-08-13 | Strategic Science & Technologies, Llc | Topical compositions containing ibuprofen or sildenafil |
WO2010151241A1 (en) | 2009-06-24 | 2010-12-29 | Strategic Science & Technologies, Llc | Topical composition containing naproxen |
EP2658554A4 (en) | 2010-12-29 | 2015-01-07 | Strategic Science & Tech Llc | SYSTEMS AND METHOD FOR THE TREATMENT OF ALLERGIES AND OTHER INDICATIONS |
ES2811515T3 (es) | 2010-12-29 | 2021-03-12 | Strategic Science & Tech Llc | Tratamiento de disfunción eréctil y otras indicaciones |
CN102885803A (zh) * | 2011-12-29 | 2013-01-23 | 广东中科药物研究有限公司 | 联苯乙酸氨丁三醇盐在制备治疗眼部炎症反应药物中的应用 |
CN104262138B (zh) * | 2014-08-22 | 2016-05-11 | 湖北美林药业有限公司 | 一种联苯乙酸化合物及其药物组合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59222409A (ja) * | 1983-06-01 | 1984-12-14 | Nippon Redarii Kk | 消炎鎮痛ゲル軟膏剤 |
JPS63174924A (ja) * | 1987-01-14 | 1988-07-19 | Toko Yakuhin Kogyo Kk | 軟膏基剤および軟膏剤 |
-
1988
- 1988-04-21 GB GB8809424A patent/GB2217595B/en not_active Expired - Fee Related
-
1989
- 1989-03-28 EP EP89105459A patent/EP0338291A1/en not_active Ceased
- 1989-04-14 NZ NZ228750A patent/NZ228750A/en unknown
- 1989-04-18 JP JP1096547A patent/JPH026407A/ja active Pending
- 1989-04-19 PT PT90313A patent/PT90313A/pt not_active Application Discontinuation
- 1989-04-20 ZA ZA892922A patent/ZA892922B/xx unknown
- 1989-04-20 KR KR1019890005214A patent/KR890015732A/ko not_active Application Discontinuation
- 1989-04-20 FI FI891886A patent/FI891886A/fi not_active Application Discontinuation
- 1989-04-20 NO NO89891618A patent/NO891618L/no unknown
- 1989-04-20 AU AU33251/89A patent/AU615736B2/en not_active Ceased
- 1989-04-20 DK DK193089A patent/DK193089A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FI891886A0 (fi) | 1989-04-20 |
DK193089D0 (da) | 1989-04-20 |
FI891886A (fi) | 1989-10-22 |
ZA892922B (en) | 1989-12-27 |
NO891618L (no) | 1989-10-23 |
NO891618D0 (no) | 1989-04-20 |
AU615736B2 (en) | 1991-10-10 |
JPH026407A (ja) | 1990-01-10 |
GB8809424D0 (en) | 1988-05-25 |
NZ228750A (en) | 1991-05-28 |
PT90313A (pt) | 1989-11-10 |
EP0338291A1 (en) | 1989-10-25 |
GB2217595A (en) | 1989-11-01 |
AU3325189A (en) | 1989-10-26 |
DK193089A (da) | 1989-10-22 |
GB2217595B (en) | 1991-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR890015732A (ko) | 소염성 겔 | |
KR830005849A (ko) | 수중에서 이버멕틴의 용매화 | |
KR880010769A (ko) | 안정한 안과용 수성 조성물 및 그 제조방법 | |
KR840009295A (ko) | α-L-아스파르틸-L-페닐아라딘 메틸에스테르 및 그의 염산염의 제조방법 | |
KR840005340A (ko) | 국소용 소염조성물의 제조방법 | |
KR890008086A (ko) | 사이클로헥산 유도체 | |
KR830005846A (ko) | 치과용 조성물 | |
KR870005681A (ko) | 겔상 에멀젼 및 이들로 부터 얻어지는 o/w 에멀젼 | |
KR900000335A (ko) | 히드록시알킬시스테인 유도체 및 이를 함유하는 거담제 | |
KR830001214A (ko) | 1,2,4,5-테트라-알킬-4-아릴피페리딘 | |
KR910009279A (ko) | 세포 보호제 조성물 | |
KR880011314A (ko) | 점착성 그리이스 조성물 | |
KR870000361A (ko) | 경화 활성화 중합체 조성물의 제조방법 | |
KR890003752A (ko) | 2-피리미디닐-피페라딘 유도체의 용도 | |
KR870005968A (ko) | 아미드 유도체 및 이를 함유하는 외용약제 | |
KR910007509A (ko) | 친유성 약제용 주사 조성물 | |
KR880007058A (ko) | 피부외용제 | |
KR920701220A (ko) | 신규의 복핵 백금 착체 및 이를 유효성분으로하는 항종양제 | |
KR880003621A (ko) | 의약 제제물 | |
KR870003097A (ko) | (+)-6-클로로-5,10-디하이드로-5-[(1-메틸-4-피페리디닐)아세틸]-11H-디벤조 [b,e][1,4] 디아제핀-11-온의 분리방법 | |
KR850007582A (ko) | 모노아실 폴리알킬렌 폴리아민의 제조방법 | |
KR870009712A (ko) | 화장품용 알코올을 다량 함유한 고점성 액의 제조방법 | |
KR870006024A (ko) | 니자티딘의 제조방법 | |
KR890014122A (ko) | 한천을 이용한 암진단용 밀론시약 제형 | |
KR900012959A (ko) | 중합체 에멀션 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITB | Written withdrawal of application |